On March 31, 2017, the United States Food and Drug Administration issued a notice regarding a voluntary recall of the EpiPen and EpiPen Jr as a result of a potential defect that could make the device difficult to activate in an emergency.  While the incidence of defect is extremely rare; the recall was expanded as a measure of caution since it may represent a potential health hazard or safety risk to enrollees.

For more information regarding the affected products, call Mylan Customer Relations at 1-800-796-9526 or visit You may also call the FDA consumer inquiry line at 1-888-INFO-FDA (1-888-463-6332) or visit

Additional information